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This is one article in an occasional PLOS
Medicine series on research integrity that
examines issues affecting the ethics of health
research worldwide.
Introduction
An increasing number of public and
commercial initiatives invite individuals to
participate in scientific research via the
internet (Table 1). People are asked to
provide information about personal med-
ical history, medications, physical traits
and measurements, ethnicity/ancestry,
lifestyle and environmental exposures,
and to donate biological material, gener-
ally saliva or blood, for DNA analysis.
Some initiatives, such as the Personal
Genome Project, have been launched with
the specific goal of conducting scientific
research, whereas others perform scientific
analyses using data that were at least
partly collected for other purposes. For
example, PatientsLikeMe is an online
community where patients can share
information on symptoms, health state,
and treatments to learn from each others’
experiences, and the company 23andMe
sells personal genome tests to individuals
who want to learn their genetic risks of
common diseases, carrier status of rare
diseases, response to drug treatment, and
ancestry. Data are collected predominant-
ly through self-report online question-
naires and some initiatives offer the
opportunity to make data accessible for
the public. For example, the Personal
Genome Project publishes anonymized
data online and participants of Patients-
LikeMe can choose to publish all data
publicly available on the web or make data
accessible only to registered users.
Strong claims regarding the benefits of
research using these resources are often made
in order to encourage individuals to provide
personal (health) information. For example,
23andWe, the research arm of 23andMe
‘‘gives customers the opportunity to leverage
their data by contributing it to studies of
genetics. With enough data, we believe
23andWe can produce revolutionary findings
that will benefit us all’’ [1]. PatientsLikeMe
tells patients that sharing personal stories and
health data does not only enable individuals
to ‘‘put your disease experiences in context
and find answers to the questions you have’’
but also gives ‘‘the opportunity to help
uncover great ideas and new knowledge’’
[2]. But how valid are these claims? Can
online data collection lead to major break-
throughs in health research? We worry that
overstating the conclusions that can be drawn
from these resources may impinge on
individual autonomy and informed consent.
Just as researchers must take care to
accurately convey direct benefits to study
participants (which, we argue, in these
situations are often small), they should also
describe the likely outcomes and known
limitations of observational studies conducted
using volunteers. Clarity regarding the ben-
efits of research using solicited personal data
is particularly important when the data
collected are also used for other purposes
(e.g., PatientsLikeMe may sell members’
information to pharmaceutical and insurance
companies [2]), lest the allure of participation
in a scientific study be used as a Trojan horse
to entice individuals to part with information
they might not otherwise volunteer.
‘‘Revolutionary’’ Findings?
As early examples of such initiatives,
23andMe and PatientsLikeMe have al-
ready published their first scientific results.
Using self-reported phenotypic data pro-
vided by their customers, 23andMe report-
ed that they replicated over 180 genetic
associations from the catalogue of genome-
wide association studies (GWAS) of the
National Human Genome Research Insti-
tute’s Office of Population Genomics [3],
identified genetic associations for miscella-
neous traits long suspected of having a
genetic basis [4], and identified two novel
loci and a substantial genetic component
for Parkinson disease [5]. And in a study of
447 patients, PatientsLikeMe showed that
lithium carbonate did not affect the rate of
progression in amyotrophic lateral sclerosis
(ALS) [6].
But how valid and new are these findings?
One of the loci for Parkinson disease that
23andme discovered was confirmed in col-
laboration with the International Parkinson
Disease Genomics Consortium [7], but the
other loci need further replication [8,9], and
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also the newly identified associations for
various traits still need to be replicated in
independent samples [4]. The replication of
180 associations concerned 144 out of 392
attempted associations in case-control and
quantitative phenotypes from the GWAS
catalogue and 39 out of 106 attempted
associations with phenotypes that were in
weak correspondence with those in the
catalogue. In both instances, the observed
percentage of replications was less than
expected based on the statistical power for
each of the phenotypes tested [3]. And finally,
as acknowledged by the authors, the absence
of an association between lithium carbonate
and ALS progression reported by Patients-
LikeMe was in line with earlier observations
and two prematurely stopped randomized
clinical trials [10,11]. Still, it is not clear that
the absence of a statistically significant finding
of this particular study can be interpreted as
the absence of a treatment effect, given the
methodological limitations in online data
collection. Using self-reported data from
self-selected individuals is subject to several
known biases in the presence of which
reported frequencies, prevalences, and asso-
ciations can be over- or underestimated.
Table 2 lists the sources of bias in observa-
tional studies that are commonly observed
but particularly relevant for studies using self-
reported data from self-selected individuals
[12]: selection bias, information bias, and
confounding.
Sources and Implications of
Bias
The first source of bias, selection bias,
occurs when the study population does not
represent the target or sampling population,
for example when customers of personal
genome tests are healthier, higher educated
than the general population [13], or when
participating patients are more motivated,
literate, and empowered [14,15]. Selection
bias is also observed when participation in a
study by cases is related to a certain risk factor
and participation amongst control individuals
is unrelated to that factor, e.g., when
depressed people are less likely to join online
communities. In that example, the validity of
studies in psychiatric, neurological, and
geriatric diseases might be reduced, because
the frequency of the risk factor in cases and its
impact on disease risk are likely underesti-
mated. Statistical techniques, such as inverse-
probability sample weighting, can correct the
effects of selection bias, but these require that
the sampling population is known. The fact
that the sampled population is unknown is a
major shortcoming in studies that recruit
online through participant self-selection.
The second source of bias, information
bias, concerns any systematic error in the
collection of data. Errors in exposure
reporting that are unrelated to the pheno-
type being studied (‘‘non-differential mis-
classification’’) cannot create an association
when none truly exists, although they can
attenuate the estimated size of a true
association. Of greater concern, errors that
are related to the phenotype being studied
(‘‘differential misclassification’’) can create
spurious associations where none exist, or
over- or underestimate the size of true
associations. For example, individuals with
a disease may recall their exposure history
differently than those without (reporting and
recall biases), especially if the exposure is
widely suspected to be linked to the disease.
Misclassification of outcome typically
occurs for outcomes that apparently follow
from certain exposures (detection bias). In
studies with continuous online data collec-
tion, outcome misclassification may be
particularly troublesome because partici-
pants may report their phenotype status
after learning about their risk factors and
Summary Points
N An increasing number of public/private initiatives are exploring novel ways of
conducting scientific research, including the use of social media and online
collection of self-reported data.
N Research relying on collection of self-reported data by self-selected participants
has known methodological limitations, including selection bias, information
bias, and confounding.
N Such limitations may mean that results and conclusions of research using data
obtained through online communities need to be interpreted with caution, as
further replication is often required.
N The findings of research, including their potential actionability, should be
communicated to participants in a way that is understandable, accurate,
complete, and not misleading.
N The potential for sharing participants’ data with third parties as well as the
commercial uses of research findings should be disclosed to participants prior
to consent.
Table 1. Examples of online research initiatives.
Initiative Aims and Claims
PatientsLikeMe.org ‘‘To provide a better, more effective way for you to share your real-world health experiences in order to help yourself, other patients like
you and organizations that focus on your conditions.’’
23andMe.com ‘‘Our research arm, 23andWe, gives customers the opportunity to leverage their data by contributing it to studies of genetics. With
enough data, we believe 23andWe can produce revolutionary findings that will benefit us all.’’
Personal Genome Project
(personalgenomes.org)
‘‘The mission of the Personal Genome Project is to encourage the development of personal genomics technology and practices that: are
effective, informative, and responsible; yield identifiable and improvable benefits at manageable levels of risk; are broadly available for
the good of the general public.’’
DIYgenomics.com ‘‘A non-profit research organization founded in March 2010 to realize personalized medicine through crowdsourced health studies and
apps.’’
Genomera.coma ‘‘We’re crowd-sourcing health discovery by helping anyone create group health studies.’’
Curetogether.comb ‘‘Bringing patients into research as active partners is one of our big missions at CureTogether.’’ [21]
Quoted information was downloaded from the organizations’ websites on July 1, 2012.
aBeta version.
bAcquired by 23andMe.
doi:10.1371/journal.pmed.1001328.t001
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their impact on the phenotype [4,16].
23andMe suspected this source of bias for
several traits, including athletic perfor-
mance [4]. They observed that self-report
of athletic status, i.e., performance in sprint
or endurance races, was more in line with
the observed genotype-phenotype associa-
tion among customers who had viewed
their genotype status prior to completing
the questionnaire. Information bias might
also be a problem when openness of data is
encouraged such as with PatientsLikeMe.
Patients can view risk factors and symptoms
of other individuals before they complete
their questionnaire, which may lead to
biased representation of the clustering of
symptoms. In general, self-reported data
are known to be subject to misclassification
of outcome because lay people are less
aware of formal definitions and diagnostic
criteria. Misclassification in the outcome
variable is a serious concern, particularly
when epidemiological associations are ex-
pected to be small, such as is in genetic
studies in multifactorial diseases.
The third source of bias, confounding,
occurs when two variables are associated
because both are associated to a third
that might explain the association be-
tween the two. Confounding can be
effectively dealt with using stratified or
multivariable regression analyses when
the confounding variables are measured.
An advantage of online data collection is
that additional questions can be asked of
participants, but there are sources of
confounding that cannot be solved this
way. It is difficult to reliably assess
confounders retrospectively and to cor-
rect bias that is caused by confounders
that affect the probability of participa-
tion. Examples of potential confounders
that may be associated with the proba-
bility of participation in online studies
are socio-economic status and health
literacy.
Opportunities for Research
While these biases can greatly affect
the interpretation and generalizability of
what can be done with self-reported
data collected from volunteers, there are
many situations where these data may
prove useful. First, analyses can be done
on risk factors and outcomes that are
less susceptible to misclassification be-
cause the phenotype definition or meth-
ods of assessment are straightforward,
such as for demographic information
and for diseases that less likely remain
undiagnosed, e.g., cancer, Parkinson
disease, and ALS. Second, the data
can be used for analyses where the
selection of individuals is the preferred
study design. Many gene discovery
studies are performed using so-called
extreme group comparisons, i.e., com-
paring patients with screened controls
or comparing patients with a family
history of disease with unscreened con-
trols. Screening controls on the absence
of any symptoms related to the disease
of interest may compensate for potential
misclassification of the outcome. And
third, the data can still be used in
analyses for which the presence of bias
does not affect the conclusion of the
study—analyses where bias may affect
the magnitude of association, but not
the presence of association. When ex-
pected associations are large or when
the sample size is large, associations may
still be significant in the presence of
misclassification. But other than these,
the opportunities for research are limit-
ed, as the results obtained using self-
reported data from self-selected individ-
uals may not easily withstand skepticism
about the biased approach.
Concluding Remarks
The new initiatives of public participation
in science (citizen science) by online and
continuous data collection have changed our
views on how to most efficiently and
effectively conduct scientific studies [17],
and their greatest value may be in that area.
These initiatives can speed up scientific
research by facilitating the recruitment of
participants in a relatively easy way, which is
particularly relevant for rare diseases such as
ALS and Parkinson disease. PatientsLikeMe
has a trial search tool, linked to clinical-
trials.gov, through which patients can see
which trials are still recruiting [2]. And with
their rich data collections and online
opportunities for fast data updates, they
can quickly put new topics on the scientific
agenda and question published observation-
al studies and trials. An excellent example
was provided by 23andMe. Within a week
of the high-profile publication of a putative
genetic predictor of longevity, 23andMe
showed that the predictor did not replicate
in their data. After re-examination of their
study protocol and data analysis, the authors
of the longevity study retracted their initial
publication [18,19]. Nevertheless, the biases
in the design and data collection of the
citizen science organizations warrant that
most conclusions from their studies need
further replication.
Initiators of online data collections are
strong advocates of openness and trans-
Table 2. Biases in observational studies and their potential effect when using self-report data from self-selected individuals [12].
Bias Problem When:
Selection bias Bias occurring in the selection of the population: population studied is not representative for target population
Ascertainment bias Inappropriate definition of the eligible population
Non-participation bias Non-participation is related to the outcome or risk factors investigated, e.g., depression
Healthy volunteer bias Participants are healthier than general or target population
Information bias Bias occurring during data collection: systematic measurement error
Misclassification bias Imperfections in procedure to classify exposures or disease status
Detection bias Presence of risk factors increases probability that disease is diagnosed
Recall bias Recall of risk factors differs between individuals patients and nonpatients
Reporting bias Reporting of risk factors differs between patients and nonpatients, e.g., patients with lung cancer may underreport smoking status
Hawthorne effect Awareness of being observed influences outcome of the study, e.g., participants complete exposure/disease status on the basis of
observed associations
Confounding Observed risk factor is correlated with unmeasured risk factor
By indication Prognostic factors influence treatment decisions
doi:10.1371/journal.pmed.1001328.t002
PLOS Medicine | www.plosmedicine.org 3 October 2012 | Volume 9 | Issue 10 | e1001328
parency, but they are relatively reserved
about the methodological limitations of
their research in communications to their
participants. Their scientific papers ac-
knowledged and extensively discussed the
limitations of their study designs and data
collection, including the need for replica-
tion of the findings and the need for
further research [3–6,20], but this concern
is not necessarily reflected on their web-
sites, where they encourage people to
provide information and where they list
and describe their scientific discoveries.
Presenting results without a proper expla-
nation and disclaimer is however not
without risks. When PatientsLikeMe re-
ports that lithium does not reduce ALS
progression, will patients discontinue treat-
ment? Will they still trust their doctors
when they were prescribed a drug that
apparently does not work? Researchers
should clearly explain the limitations of
their approach and their findings and
stress that participants should not change
their medical regimens without consulta-
tion of their doctor (Table 3).
We have focused on the ethical impli-
cations of methodological limitations of
research involving self-reported data from
self-selected participants. Research using
data obtained through online communities
faces new dilemmas in relation to old
issues, which require further ethical anal-
ysis and public debate, including the
provision of adequate consent, the safe-
guard of public trust, disclosure of com-
mercial development of research results,
and the sale of participants’ data to third
parties [17]. Only a responsible approach
with realistic expectations about what can
be done with and concluded from the data
will benefit science in the long run.
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Table 3. Recommendations for communicating opportunities and limitations of research conducted using data obtained through
online communities.
Timeline Recommendations and/or Limitations
Before data collection: Information about what can and cannot be done with the data collected
Clear discussion of immediate benefits that study participants may or may not receive
Presentation of realistic and fair claims about scientific knowledge that is likely to be gained
Disclosure about potential for sharing participants’ data with third parties as well as the commercial uses of research findings
After data analyses: Comprehensive and balanced presentation of research results
Clear interpretation of results, especially in light of other studies and need for replication
Discussion of implications for health behavior or medical decisions, if any
doi:10.1371/journal.pmed.1001328.t003
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